|
Name |
paecilin H
|
Molecular Formula | C34H36O14 | |
IUPAC Name* |
methyl5-hydroxy-6-[5-hydroxy-2-methoxycarbonyl-2-(5-methoxy-3-methyl-5-oxopentan-2-yl)-4-oxo-3H-chromen-8-yl]-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromene-2-carboxylate
|
|
SMILES |
COC(=O)CC(C)C(C)C1(C(=O)OC)CC(=O)c2c(O)ccc(-c3ccc4c(c3O)C(=O)CC(C(=O)OC)(C3OC(=O)CC3C)O4)c2O1
|
|
InChI |
InChI=1S/C34H36O14/c1-15(11-24(38)43-4)17(3)33(31(41)44-5)13-21(36)26-20(35)9-7-19(29(26)48-33)18-8-10-23-27(28(18)40)22(37)14-34(47-23,32(42)45-6)30-16(2)12-25(39)46-30/h7-10,15-17,30,35,40H,11-14H2,1-6H3/t15-,16-,17+,30+,33-,34-/m0/s1
|
|
InChIKey |
UQSJSUFVWDVBGK-VNFIZSSCSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 668.65 | ALogp: | 3.3 |
HBD: | 2 | HBA: | 14 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 198.3 | Aromatic Rings: | 5 |
Heavy Atoms: | 48 | QED Weighted: | 0.301 |
Caco-2 Permeability: | -5.109 | MDCK Permeability: | 0.00003170 |
Pgp-inhibitor: | 0.924 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.615 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.835 |
Blood-Brain-Barrier Penetration (BBB): | 0.02 | Plasma Protein Binding (PPB): | 86.31% |
Volume Distribution (VD): | 0.408 | Fu: | 6.13% |
CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.772 |
CYP2C19-inhibitor: | 0.407 | CYP2C19-substrate: | 0.18 |
CYP2C9-inhibitor: | 0.839 | CYP2C9-substrate: | 0.557 |
CYP2D6-inhibitor: | 0.038 | CYP2D6-substrate: | 0.2 |
CYP3A4-inhibitor: | 0.926 | CYP3A4-substrate: | 0.711 |
Clearance (CL): | 14.322 | Half-life (T1/2): | 0.103 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.879 |
Drug-inuced Liver Injury (DILI): | 0.972 | AMES Toxicity: | 0.023 |
Rat Oral Acute Toxicity: | 0.913 | Maximum Recommended Daily Dose: | 0.05 |
Skin Sensitization: | 0.009 | Carcinogencity: | 0.095 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.005 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005727 | 0.884 | D0T5XN | 0.272 | ||||
ENC005732 | 0.806 | D07IPB | 0.258 | ||||
ENC005735 | 0.806 | D01UBX | 0.257 | ||||
ENC005736 | 0.742 | D0Q0PR | 0.251 | ||||
ENC005730 | 0.727 | D01XWG | 0.246 | ||||
ENC005734 | 0.725 | D07VLY | 0.242 | ||||
ENC003346 | 0.660 | D0C9XJ | 0.242 | ||||
ENC005728 | 0.650 | D01XDL | 0.239 | ||||
ENC003348 | 0.645 | D0T8EH | 0.232 | ||||
ENC005733 | 0.610 | D0F7CS | 0.225 |